Plasma membrane Ca²⁺-ATPase (PMCA) translocates to filopodia during platelet activation

Summary

The plasma membrane Ca²⁺-ATPase (PMCA) plays an essential role in maintaining low cytosolic Ca²⁺ in platelets. Recently we demonstrated that PMCA is recruited to the cytoskeleton by interacting with PDZ domains. In the present study we determined the subcellular localization of PMCA using immunofluorescence microscopy. In resting platelets PMCA was distributed over the entire plasma membrane. Upon activation with thrombin, PMCA was found in filopodia adjacent to the actin cytoskeleton. PMCA translocation to filopodia was prevented by a peptide containing the last 10 residues of PMCA4b, the predominate isoform of PMCA in platelets, which contains a known PDZ domain-binding motif and was previously shown to block association of PMCA with the cytoskeleton. Incorporation of the PMCA C-terminal peptide did not affect the rate or extent of platelet aggregation, but significantly enhanced the rate of clot retraction. These results show that PMCA association with the cytoskeleton during platelet activation results in translocation of this Ca²⁺-pump to filopodia and that this association may affect later stages of platelet activation. The consequence of PMCA translocation to filopodia is likely a reduction in the local concentration of free Ca²⁺ in these structures resulting in regulation of the rate of clot retraction.

Keywords

Platelets - plasma membrane Ca²⁺-ATPase - filopodia - calcium signaling

• References

• 1 Axelsen KB, Palmgren MG. Evolution of substrate specificities in the P-type ATPase superfamily. J Mol Evol 1998; 46: 84-101.
• 2 Carafoli E. Calcium pump of the plasma membrane. Physiol Rev 1991; 71: 129-53.
• 3 Garcia ML, Strehler EE. Plasma membrane calcium ATPases as critical regulators of calcium homeostasis during neuronal cell function. Front Biosci 1999; 04: D869-D882.
• 4 Stauffer TP, Guerini D, Carafoli E. Tissue distribution of the four gene products of the plasma membrane Ca²+ pump. A study using specific antibodies. J Biol Chem 1995; 270: 12184-90.
• 5 Dean WL, Chen D, Brandt PC. et al.. Regulation of Platelet Plasma Membrane Ca²⁺-ATPase by cAMP-dependent and Tyrosine phosphorylation. J Biol Chem 1997; 272: 15113-9.
• 6 Martin V, Bredoux R, Corvazier E. et al.. Platelet Ca²⁺-ATPases: a plural, species-specific, and multiple hypertension-regulated expression system. Hypertension 2000; 35: 91-102.
• 7 Paszty K, Kovacs T, Lacabaratz-Porret C. et al.. Expression of hPMCA4b, the major form of the plasma membrane calcium pump in megakaryoblastoid cells is greatly reduced in mature human platelets. Cell Calcium 1998; 24: 129-35.
• 8 Wan TC, Zabe M, Dean WL. Plasma membrane Ca2+-ATPase isoform 4b is phosphorylated on tyrosine 1176 in activated human platelets. Thromb Haemost 2003; 89: 122-31.
• 9 Haynes DH. Effects of Cyclic Nucleotides and Protein Kinases on Platelet Calcium Homeostasis and Mobilization. Platelets 1993; 04: 231-42.
• 10 Rosado JA, Sage SO. Regulation of plasma membrane Ca²⁺ ATPase by small GTPases and phosphoinositides in human platelets. J Biol Chem 2000; 275: 19529-35.
• 11 Fox JEB. The Platelet Cytoskeleton. Thromb Haemost 1993; 70: 884-93.
• 12 Eigenthaler M, Shattil SJ. Integrin signaling and the platelet cytoskeleton. Current Topics in Membranes 1996; 43: 265-91.
• 13 Inoue O, Suzuki-Inoue K, Dean WL. et al.. Integrin α₂β₁ mediates outside-in regulation of platelet spreading on collagen through activation of Src kinases and PLC2. J Cell Biol 2003; 160: 769-80.
• 14 Garner CC, Nash J, Huganir RL. PDZ domains in synapse assembly and signaling. Trends Cell Biol 2000; 10: 274-80.
• 15 Kim E, DeMarco SJ, Marfatia SM. et al.. Plasma Membrane Ca²⁺-ATPase isoform 4b binds to membrane-associated guanylate kinase (MAGUK) proteins via their PDZ (PSD-95/Dlg/ZO-1) domains. J Biol Chem 1998; 273: 1591-5.
• 16 DeMarco SJ, Strehler EE. Plasma Membrane Ca²⁺-ATPase isoforms 2b and 4b interact promiscuously and selectively with members of the membrane-associated guanylate kinase family of PDZ (PSD-95/Dlg/ZO-1) domaincontaining proteins. J Biol Chem 2001; 276: 21594-600.
• 17 Zabe M, Dean WL. Plasma membrane Ca^{2+ -}ATPase associates with the cytoskeleton in activated platelets through a PDZ-binding domain. J Biol Chem 2001; 276: 14704-9.
• 18 Fox JEB, Boyles JK, Reynolds CC. et al.. Actin filament content and organization in unstimulated platelets. J Cell Biol 1984; 98: 1985-91.
• 19 Borke JL, Caride A, Verma AK. et al.. Plasma membrane calcium pump and 28-kDa calcium binding protein in cells of rat kidney distal tubules. Am J Physiol 1989; 257: F842-F849.
• 20 Authi KS, Rao GH, Evenden BJ. et al.. Action of guanosine 5’-[beta-thio]diphosphate on thrombin-induced activation and Ca²+ mobilization in saponin-permeabilized and intact human platelets. Biochem J 1988; 255: 885-93.
• 21 Schraw TD, Lemons PP, Dean WL. et al.. A role for Sec1/Munc18 proteins in platelet exocytosis. Biochem J 2003; 374: 207-17.
• 22 Cheresh DA, Leng J, Klemke RL. Regulation of cell contraction and membrane ruffling by distinct signals in migratory cells. J Cell Biol 1999; 146: 1107-16.
• 23 Osdoit S, Rosa J-P. Fibrin clot retraction by human platelets correlates with α_IIbβ₃ integrindependent protein tyrosine dephosphorylation. J Biol Chem 2001; 276: 6703-10.
• 24 Schoenwaelder SM, Kulkarni S, Salem HH. et al.. Distinct substrate specificities and functional roles for the 78-and 76-kDa forms of µ-calpain in human platelets. J Biol Chem 1997; 272: 24876-84.
• 25 Gomez TM, Robles E, Poo M. et al.. Filopodial Calcium transients promote substrate-dependent growth cone turning. Science 2001; 291: 1983-6.
• 26 Zheng JQ. Turning of nerve growth cones induced by localized increases in intracellular calcium ions. Nature 2000; 403: 89-93.
• 27 Croce K, Flaumenhaft R, Rivers M. et al.. Inhibition of calpain blocks platelet secretion, aggregation, and spreading. J Biol Chem 1999; 274: 36321-7.
• 28 Rutledge TW, Whiteheart SW. SNAP 23 is a target of calpain cleavage in activated platelets. J Biol Chem 2002; 277: 37009-15.